Search on Site

Explore our comprehensive database of pharmaceutical news releases, press releases, events, and industry insights with ease. Effortlessly find relevant information tailored to your interests and stay updated on the latest developments in the pharmaceutical sector. Start searching now to uncover valuable insights and resources for your pharmaceutical endeavors.

IKA introduces new accessories for the HABITAT research bioreactor.

technology, extends its range of accessories and sensors for the award-winning HABITAT research bioreactor. This 3-in-1 bioreactor, fermenter, and photobioreactor now boasts additional tools to provide more options for today's researchers,...

Carterra unveils Carterra Ultra™, its most sensitive biosensor platform, advancing fragment and small molecule drug discovery

volume as Carterra's first two systems while also delivering the utmost sensitivity to characterize molecules as small as 100 Daltons. Ultra boasts enhanced optics, advanced microfluidics, and thermals capable of high-sensitivity measurements in an...

PANTHERx® Rare is selected by Calliditas Therapeutics as the specialty pharmacy for TARPEYO®.

FDA-approved treatment to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN).1 Primary immunoglobulin A nephropathy (IgAN or Berger's Disease) is a rare, progressive, chronic autoimmune disease that...

MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing

the intelligence of devices – the company is everywhere. In 2023, Merck KGaA, Darmstadt, Germany, generated sales of € 21 billion in 65 countries. The company holds the global rights to the name and trademark “Merck” internationally. The only...

Onco360 now offers LAZCLUZE™ (lazertinib) with Rybrevant® for first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations

chemotherapy-free regimen, of adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have EGFR exon 19 deletions of exon 21 L858R mutations, as detected by an FDA-approved test. This new regimen shows superior...

Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season

COVID vaccines from Pfizer and Moderna along with the annual flu vaccine, in anticipation of a challenging flu and COVID-19 season, as forecasted by the Centers for Disease Control and Prevention (CDC). “Albertsons Cos. pharmacies provide dedicated...

Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits

for the target host cell line as opposed to off-target DNA. The FAM-labeled nucleic acid probe is quenched by BHQ-1™ until PCR extension. The kits are compatible with any qPCR instrument that detects FAM signal, eliminating the added cost of...

Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic

CVS Health® announced that the updated 2024-2025 COVID-19 vaccines and flu vaccines are available at CVS Pharmacy® and MinuteClinic® locations nationwide. Walk-ins are being accepted at CVS Pharmacy and the company's digital vaccine scheduler has...

ProJenX announces the formation of its Clinical Advisory Board

brain-penetrant, MAP4 kinase (MAP4K) inhibitor—and additional pipeline programs. Prosetin is being evaluated in Study PRO-101, a hybrid Phase 1 clinical trial designed to evaluate its safety, tolerability, pharmacokinetics, and pharmacodynamics in...

Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics

pathologists using their cutting edge-technology and tools in routine practice around the world. The company has seen a 157% increase in patient cases processed monthly via Ibex’s AI solution and 178% rise in new customers, reflecting its expanded...

Find Therapeutics announces FDA clearance of its IND application for a Phase 1 study of FTX-101 to treat chronic optic neuropathy

that the U.S. Food and Drug Administration ("FDA") has cleared its Investigational New Drug ("IND") application for FTX-101, enabling the company to initiate its planned Phase 1 clinical study of FTX-101 in healthy volunteers. The company...

China approves the Corina Intrauterine Drug-Eluting System as a novel treatment for moderate-to-severe intrauterine adhesions (IUA)

("Corina"), developed by Yipurun (Shanghai) Biotechnology Co., Ltd. ("YPR"), has received approval in China (G.X.Z.Z. 20243181461) for use in patients with moderate-to-severe intrauterine adhesions (IUA) who undergo transcervical resection of...

Trinity Life Sciences introduces new customer engagement solutions, leveraging its deep commercial insight and renowned technology platform

develop the right drugs and devices for today’s market and optimize them once in market. We have a diverse staff of over 1200 people and 11 global offices across the U.S., Europe and Asia. Ultimately, we know that every decision our clients make...

ImmPACT Bio announces FDA clearance of its IND application for CD19/CD20 bispecific CAR-T cell therapy in multiple sclerosis

the United States Food and Drug Administration (FDA) has cleared an investigational new drug application (IND) for IMPT-514, a CD19/CD20 bispecific chimeric antigen receptor (CAR) T-cell therapy for the treatment of adult patients with multiple...

Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis

In the study, 62% of participants taking Livdelzi achieved the primary endpoint of composite biochemical response at month 12, versus 20% of participants taking placebo. Treatment with Livdelzi led to normalization of alkaline phosphatase (ALP)...

Vapourtec Unveils Peptide-ExplorerLT: A Breakthrough Tool for Chemists in Linear Peptide Synthesis Optimization

simple addition of further modules and a software license. “A key benefit is the reduced space required. The system is only 107 cm wide x 54 cm deep x 109 cm in height and these dimensions include space for solvent containers and waste,” added Dr....

OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award

Transparency Monitor at the National Association of Chain Drug Stores – Total Store Expo (NACDS TSE), to be held August 17-19 in Boston. The pharmacy-specific interactive visualization tool was developed to provide pharmacies with billing...

Aptar’s Nasal Unidose System will deliver neffy® (epinephrine nasal spray), the first FDA-approved needle-free treatment for Type I allergic reactions, including anaphylaxis

homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit www.aptar.com. About ARS Pharmaceuticals: ARS is a...

Bavarian Nordic gets a HERA order and announces a major vaccine donation for the Mpox outbreak in Africa

and Response Authority) for the Company’s MVA-BN® vaccine, the only FDA and EMA-approved mpox vaccine. HERA will procure 175,420 doses of the vaccine for donation to the Africa CDC (Centres for Disease Control and Prevention) in support of their...

Derm-Biome Pharmaceuticals to develop skincare treatment that promotes skin health and longevity

fibres, ultimately leading to wrinkles and sagging skin. Studies have shown that blocking cytokines such as interleukin 17 (IL-17) during the aging process can delay the development of several hallmarks of skin aging. Derm-Biome is advancing a...